Antitumor effect of allogenic fibroblasts engineered to express Fas ligand (FasL)

  1. Drozdzik, M.
  2. Qian, C.
  3. Lasarte, J.J.
  4. Bilbao, R.
  5. Prieto, J.
Journal:
Gene Therapy

ISSN: 0969-7128

Year of publication: 1998

Volume: 5

Issue: 12

Pages: 1622-1630

Type: Article

DOI: 10.1038/SJ.GT.3300763 GOOGLE SCHOLAR

Sustainable development goals